# Eyebiotech Ltd — Form D

Eyebiotech Ltd of HOLBORN, LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-19. The offering totals $486, of which $486 was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-08-19
- Form: D
- Accession: 0001878733-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $486
- Amount sold: $486
- Investors: 1
- Date of first sale: 2021-08-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-410579

## Issuer

- Name: Eyebiotech Ltd
- CIK: 0001878733
- Entity type: Other
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2021
- Address: INTERNATIONAL BUILDING, 71 KINGSWAY, HOLBORN, LONDON, X0, WC2 6ST
- Phone: 44 07827 330296

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Catherine Elizabeth Bingham | Director | Holborn, London, X0 |
| James Allister John Costine | Director | Holborn, London, X0 |
| David Robert Guyer | Executive Officer | Holborn, London, X0 |
| Michael Jay Ross | Executive Officer | Holborn, London, X0 |

## More

- [CIK 1878733 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1878733&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001878733-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.